These factors were previously retrieved by gene expression profiling as being up-regulated via MAPK signaling in KRAS mutant colorectal cancer cells20 as well as in mesenchymal and epithelial cells transformed by HRAS and KRAS oncogenes, respectively21,22. This evidence concerns the gene KRAS and colorectal cancer.